Influence of oligopeptide transporter binding affinity upon uptake and transport of D-Asp(OBzl)-Ala and Asp(OBzl)-Sar in filter-grown Caco-2 monolayers

被引:18
作者
Taub, ME
Moss, BA
Steffansen, B
Frokjaer, S
机构
[1] ROYAL DANISH SCH PHARM, DEPT PHARMACEUT, DK-2100 COPENHAGEN O, DENMARK
[2] PEPTIDE TECHNOL, DK-3400 HILLEROD, DENMARK
关键词
Caco-2; oligopeptide transporter; dipeptide; uptake; transport;
D O I
10.1016/S0378-5173(97)00200-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The oligopeptide transporter, which is responsible for the absorption of various di/tripeptides and several peptidomimetic drugs across the intestinal epithelia, is expressed in mature Caco-2 monolayers. Using certain enzymatically stable dipeptides containing either L-or D-aspartic acid at the amino terminus, we investigated the relationship between a side-chain modified dipeptide's degree of binding affinity for the apically expressed Caco-2 oligopeptide transporter and its ability to undergo uptake and/or apical-to-basal transport. Two beta-esterified dipeptides, D-Asp(OBzl)-Ala and Asp(OBzl)-Sar, possess markedly different affinities for the Caco-2 oligopeptide transporter (IC50=2.62 +/- 0.35 and 0.014 +/- 0.007 mM, respectively) as determined using a [C-14]Gly-Sar cellular uptake displacement assay. D-Asp(OBzl)-Ala undergoes rapid internalization into Caco-2 monolayers (14.33 +/- 1.00 nmol/mg protein) during a 15-min uptake study; additionally, D-Asp(OBal)-Ala is efficiently transported in the apical-to-basal direction across Caco-2 monolayers (14.41+/-0.91 nmol/h/cm(2)). Both uptake and transport of D-Asp(OBzl)-Ala are > 90% inhibitable by the presence of a 20-fold molar excess of Gly-Pro in the apical chamber. Although Asp(OBzl)-Sar demonstrates a 187-fold lower IC50 value than D-Asp(OBzl)-Ala, Asp(OBzl)-Sar does not achieve uptake or transport in parallel experiments. These data indicate that a side-chain modified, enzymatically stable dipeptide, D-Asp(OBzl)-Ala, is actively taken up into and transported across Caco-2 monolayers via the oligopeptide transporter. Additionally, the degree of affinity of a side-chain modified dipeptide for the Caco-2 oligopeptide transporter is not necessarily indicative of its ability to access the oligopeptide transporter-mediated uptake and transport pathway. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 23 条
[1]   STRUCTURAL SPECIFICITY OF MUCOSAL-CELL TRANSPORT AND METABOLISM OF PEPTIDE DRUGS - IMPLICATION FOR ORAL PEPTIDE DRUG DELIVERY [J].
BAI, JPF ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1992, 9 (08) :969-978
[2]   PGLU-L-DOPA-PRO - A TRIPEPTIDE PRODRUG TARGETING THE INTESTINAL PEPTIDE TRANSPORTER FOR ABSORPTION AND TISSUE ENZYMES FOR CONVERSION [J].
BAI, JPF .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :1101-1104
[3]  
Bodansky M., 1994, PRACTICE PEPTIDE SYN, V2nd
[4]   Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells [J].
Covitz, KMY ;
Amidon, GL ;
Sadee, W .
PHARMACEUTICAL RESEARCH, 1996, 13 (11) :1631-1634
[5]  
DANIEL H, 1992, J BIOL CHEM, V267, P9565
[6]   UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
DANTZIG, AH ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) :211-217
[7]  
DANTZIG AH, 1994, BIOCHIM BIOPHYS ACTA, V1191, P1
[8]   A COMPARISON OF THE AFFINITIES OF DIPEPTIDES AND ANTIBIOTICS FOR THE DIPEPTIDE/TRIPEPTIDE TRANSPORTER IN CACO-2 CELLS [J].
EDDY, EP ;
WOOD, C ;
MILLER, J ;
WILSON, G ;
HIDALGO, IJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) :79-86
[9]   IS INTESTINAL PEPTIDE-TRANSPORT ENERGIZED BY A PROTON GRADIENT [J].
GANAPATHY, V ;
LEIBACH, FH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (02) :G153-G160
[10]   UPTAKE AND TRANSEPITHELIAL TRANSPORT OF THE ORALLY ABSORBED CEPHALOSPORIN CEPHALEXIN, IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
GOCHOCO, CH ;
RYAN, FM ;
MILLER, J ;
SMITH, PL ;
HIDALGO, IJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (03) :187-202